RxSight (RXST) insider trading in the last 6 months
4 insiders sold $118K. No buys.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Who files at RxSight
Questions about RXST's insider trades
Are RXST insiders buying or selling?
4 insiders sold $118K across 4 filings in the last 6 months. No open-market buys on record. The newest filing: Mark Wilterding, Chief Financial Officer, sold $54K on Sep 2, 2026.
Who are RXST's biggest insider sellers?
By the dollars of their sales in the last 6 months: Mark Wilterding (Chief Financial Officer), 1 sale; Ronald M. Kurtz (Chief Medical Officer), 1 sale; Eric Weinberg (Insider), 1 sale. 4 insiders sold in all.
When did an RXST insider last buy?
No RXST insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Mark Wilterding on Sep 2, 2026.
RxSight's page has its Quality Score, its chart, and its earnings. More in Healthcare and Medical Devices.